# Serotonin/Dopamine Antagonism of Cocaine Effect: 2 - 2

> **NCT00000310** · PHASE2 · TERMINATED · sponsor: **National Institute on Drug Abuse (NIDA)**

## Conditions studied

- Cocaine-Related Disorders

## Interventions

- **DRUG:** Risperidone

## Key facts

- **NCT ID:** NCT00000310
- **Lead sponsor:** National Institute on Drug Abuse (NIDA)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 1996-01
- **Primary completion:** 1996-03
- **Final completion:** 1996-03
- **Target enrollment:** 0 (—)
- **Last updated:** 2017-01-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000310

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000310, "Serotonin/Dopamine Antagonism of Cocaine Effect: 2 - 2". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00000310. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*